Vireo Growth Reports Q1 2026 Financial Results

MINNEAPOLIS – Vireo Growth Inc. released its first-quarter 2026 financial results, highlighting the early effects of an active acquisition strategy that has broadened its operations across several key Cannabis markets. The company, which operates a portfolio of retail, manufacturing, and related assets, continues to pursue a growth strategy centered on consolidation as it integrates newly acquired operations.

GAAP revenue for the period came in at $106.2 million, a 333.5% increase year-over-year, driven by a string of recently closed acquisitions. The company closed Q1 with $137.8 million in cash and says it expects to remain acquisitive. On a pro forma basis, accounting for all transactions as if they had been completed on January 1, 2025, revenue reached $210.2 million, with pro forma Adjusted EBITDA of $42.2 million, a margin of 20.1% compared to 16.2% in the same period last year.

On a reported basis, sequential quarter-over-quarter growth was modest. GAAP revenue rose just 1.6% from Q4 2025’s $104.5 million, which is exactly what you’d expect from a platform still digesting multiple simultaneous integrations. GAAP gross profit margin expanded to 55.8%, up from 50.6% a year ago, a 520-basis point improvement, suggesting the company is not simply buying revenue but is also, at least so far, holding pricing discipline.

These results reflect Vireo’s aggressive push through mergers and acquisitions. In March, Vireo completed its acquisition of a controlling interest in Schwazze’s restructured assets, adding 45 dispensaries and two manufacturing facilities across Colorado and New Mexico. The company also executed the PharmaCann management services agreement during the quarter.

Post-quarter, Vireo completed its merger with Eaze, Inc. on April 1, making the California delivery platform a wholly owned subsidiary, and closed the acquisition of The Hawthorne Gardening Company from The Scotts Miracle-Gro Company on April 8, issuing 213 million subordinate voting shares in the process. On April 13, Vireo and Glass House Brands announced a joint venture to combine their California dispensary operations (twelve locations from the Eaze acquisition alongside Glass House’s eleven retail sites) with Glass House providing preferential Cannabis supply to the combined retail platform. Recently, the company has signed a definitive agreement to absorb FLUENT Corp. in an all-stock transaction, a deal that, if approved, would make Vireo the third-largest operator in medical-only Florida’s multibillion-dollar Cannabis market.

Vireo first attracted serious attention in late 2024, when it effectively restructured itself by selling off nearly 80% of its stock, acquiring four different Cannabis operators, and aligning itself with Cannabis lending powerhouse Chicago Atlantic. Less than eighteen months later, the company has positioned itself as the fourth-largest Cannabis company on a pro forma basis by revenue.

The open question is one that follows every roll-up at speed: can the integration hold?

Colorado and New Mexico Cannabis markets face pricing compression, and pro forma Colorado and New Mexico retail revenue declined 12% year-over-year. Managing a platform that now spans delivery, retail, cultivation, hydroponic supply, and multi-state operations simultaneously is a different operational challenge than closing deals. However, with a healthy cash position and an active deal pipeline, the MSO is well-equipped to integrate disparate operations smoothly, deliver expected synergies, and generate sustainable organic growth despite competitive retail environments and shifting policy signals.